Add to Favourites
To login click here
AION Labs has announced the formation of DenovAI, their second startup approved by the Israel Innovation Authority. DenovAI will develop an AI-powered biophysics solution to discover potential antibodies from scratch and suggest candidates likely to be effective drugs. The company is backed by an alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS).